Deep Lens for Clinical Trials
Speeding patients to trials
By identifying patients at the time of diagnosis, our advanced AI-enabled patient recruitment platform compresses study timelines by finding the best-suited patients for clinical trials
Molecular Testing for Treatment of Metastatic Non-Small Cell LungCancer
The recent discovery of relevant biomarkers has reshaped our approach to therapy selection for patients with non-small cell lung cancer. The unprecedented outcomes demonstrated with tyrosine kinase inhibitors in molecularly defined cohorts of patients has underscored the importance of genetic profiling in this disease.
Critical Aspects of a Sustainable Clinical Recruitment Trial
Increasing enrollment into clinical trials is a top priority across the field of oncology. Because the vast majority of those afflicted with cancer receive their care in the community, creating strong clinical research programs in the community-based setting is important. This article comprehensively outlines the most important elements of creating and sustaining a successful community-based research program.
